Indivior Pharmaceuticals Inc

NASDAQ:INDV

Drug Manufacturers - Specialty & Generic

Healthcare
$36.28 +0.69%

+$0.26 today

Market cap
$4.53B
Beta
1.17
P/E (TTM)
19.1
EPS (TTM)
$2.00
52W Low $13.45High $41.00

Volume 3.65M

Average 2.08M

INDV Tax Payables

Taxes owed to authorities that have not yet been paid.

Indivior Pharmaceuticals IncNASDAQ: INDV

Tax Payables · Q2 FY2026 · quarter ended Jun 2026

Tax payables falls 30.2% from a year ago

Tax payables stood at $30M at the end of Q2 FY2026, down 30.2% from a year earlier and up 15.4% from the prior quarter. Over 3 fiscal years it compounded at -39.5% a year.

Context

  • Tax payables amounted to 2.4% of total assets at the end of Q2 FY2026, down 0.5 pp from a year earlier.
  • Tax payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether tax payables keeps falling in the next quarterly balance sheet after a -30.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$30M+15.4% QoQ
Last fiscal yearDec 2025
$2M-95.7% YoY
Year agoJun 2025
$43M-30.2% since
Tax Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-30.2%——
1 year-95.7%——
3-year CAGR-39.5%——
5-year CAGR——
10-year CAGR——

Tax Payables history

USD · from the balance sheet

Latest · FY2025
2M USD
Year-over-year change
-95.7%
4-year CAGR
-42.3%

Tax Payables vs competitors

How INDV compares with its peers on the latest reported figures

  • INDV's Jun 2026 tax payables of $30M is the highest of the 4 companies compared; the peer median is $0.
  • Its year-over-year change of -30.2% is the highest of 2, against a peer median of -100.0%.
  • Tax payables amounts to 2.4% of total assets for INDV, versus a peer median of 0.0%.
INDV Competitors Peer median
Tax Payables for INDV and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INDVIndivior Pharmaceuticals IncJun 2026$30M -30.2%-39.5%2.4%
ALKSAlkermes plcSep 2026$0 ——0.0%
SUPNSupernus Pharmaceuticals, Inc.Jun 2026$0 ——0.0%
COLLCollegium Pharmaceutical, Inc.Mar 2026$0 -100.0%—0.0%
Peer median (excluding INDV) $0-100.0%—0.0%

Competitors are the stored peer set for INDV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.1B778.18M316M319M195M
Short-term Investments0119.64M94M1M0
Net Receivables202M220M254M254M255M
Inventory95M114.62M135M178M153M
Other Current Assets27M18M444M34M15M
Total Current Assets1.44B1.27B1.27B839M652M
Property, Plant & Equipment (Net)95M85.46M124M139M170M
Goodwill0002M0
Intangible Assets82M70M13M5M2M
Long-term Investments098.53M41M26M28M
Tax Assets105M220.18M293M280M326M
Other Non-current Assets106M38.58M28M29M26M
Total Non-current Assets388M512.76M499M481M552M
Total Assets1.83B1.78B1.77B1.32B1.2B
Account Payables26M33M39M63M48M
Short-term Debt3M3M12M18M39M
Tax Payables18M9.05M17.97M46M2M
Deferred Revenue09.05M000
Other Current Liabilities635M391M1.16B802M722M
Total Current Liabilities804M1.02B1.29B939M914M
Long-term Debt239M237M237M315M290M
Deferred Tax Liabilities005M03M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities550M436.78M390M381M73M
Total Non-current Liabilities825M702.78M666M728M388M
Total Liabilities1.63B1.73B1.96B1.67B1.3B
Common Stock70M68.37M68M62M62M
Retained Earnings1.44B1.31B(295M)(454M)(243M)
Accumulated OCI0(1.34B)(1.35B)(46M)(30M)
Other Stockholders Equity(1.32B)01.3B00
Minority Interest00000
Total Equity203M51.28M(191M)(348M)(98M)
Total Debt286M277M283M375M351M
Net Debt(816M)(501.18M)(33M)56M156M

Indivior Pharmaceuticals Inc

NASDAQ:INDV

Intrinsic Alpha fair value

Locked

Current Price

$36.28

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.